Post job

PetCure Oncology CEO and executives

Executive Summary. Based on our data team's research, Scott Milligan is the PetCure Oncology's CEO. PetCure Oncology has 30 employees, of which 14 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The PetCure Oncology executive team is 64% female and 36% male.
  • 64% of the management team is White.
  • 16% of PetCure Oncology management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at PetCure Oncology?
Share your experience

Rate PetCure Oncology's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Scott Milligan

Chief Executive Officer

Scott Milligan's LinkedIn

Scott Milligan is a Chief Executive Officer at PetCure Oncology and is based in Chicago, Illinois. He has worked as Senior Manager at EY; Vice President - Technology Ventures at Neurosource; and Co-Founder, Partner at Accelitech LLC. Scott attended Ohio Wesleyan University between 1986 and 1990.

Eric Boshoven

Board Member

Glenna Mauldin

Board Member

Karri Meleo

Board Member

Kelsey Pohlmann

Board Member

Lauren Quarterman

Board Member

Matt Arkans

Board Member

Michelle Morges

Board Member

Molly Holmes

Board Member

Renee Al-Sarraf

Board Member

Do you work at PetCure Oncology?

Does leadership effectively guide PetCure Oncology toward its goals?

PetCure Oncology jobs

PetCure Oncology board members

Name & TitleBio
Eric Boshoven

Board Member

Glenna Mauldin

Board Member

Karri Meleo

Board Member

Kelsey Pohlmann

Board Member

Lauren Quarterman

Board Member

Matt Arkans

Board Member

Michelle Morges

Board Member

Molly Holmes

Board Member

Renee Al-Sarraf

Board Member

Rick Chetney

Board Member

What employees say about the executives at PetCure Oncology

Employee reviews
profile
1.0
A zippia user wrote a review on Oct 2024
Pros of working at PetCure Oncology

Work/life balance

Cons of working at PetCure Oncology

VP and regional manager know nothing about veterinary medicine. They have no understanding of what problems are happening Onsite. The radiation oncologist I worked with made bad decisions and was never Onsite so didn’t see the consequences.

PetCure Oncology benefits

The pay was not bad and not working weekends was nice

What do you like best about PetCure Oncology's CEO and the leadership team?

I didn’t like them. Out of touch and not showing up in person to your teams is not working well. They follow numbers very closely.

How would you improve PetCure Oncology's culture?

I would change the model completely. Remote specialist and telehealth may have been good during Covid, but not now. SRT should be done with the resources that a university has and not with small teams all on different islands. Partner hospitals hate PetCure because they are responsible many times for follow up in ER after hours and don’t know what to do.

How did you prepare for the PetCure Oncology interview?

Just learned about SRT and indications for it.

How does your compensation at PetCure Oncology compare to the industry average?

Good. The benefits were nice although difficult to take time off as there is nobody to cover.

What's the diversity at PetCure Oncology like?

Not too good. I think most people in leadership roles are of European heritage with one African American.

What brings you the most joy at PetCure Oncology?

The animals and the people that care for them.

Is this useful?
Work at PetCure Oncology? Share your experience

PetCure Oncology executives FAQs

Zippia gives an in-depth look into the details of PetCure Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about PetCure Oncology. The employee data is based on information from people who have self-reported their past or current employments at PetCure Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by PetCure Oncology. The data presented on this page does not represent the view of PetCure Oncology and its employees or that of Zippia.

PetCure Oncology may also be known as or be related to PETCURE ONCOLOGY LLC, PetCure Oncology, PetCure Oncology LLC and Petcure Oncology.